Juniper Pharmaceuticals (JNP) Inactive 10-K2012 FY Annual report

Filed: 14 Mar 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: ACA, ACOG, asymptomatic, Bay, Bedford, billion, Bulletin, capacity, Chartered, CL, clear, cleared, competitor, curtailed, Cydan, deadline, decade, demanded, denial, departure, difficulty, diligence, England, ethical, FDRR, FINRA, forfeiture, Formal, Genzyme, grace, Guideline, Hertfordshire, impossible, incidentally, India, jointly, Jonathan, led, ligation, Lloyd, machinery, maker, Mandatory, mm, morbidity, mortality, move, Nassau, NovaBay, obsolete, open, orphan, OTCBB, OTCQB, pathway, perinatal, PhamaBio, Pink, proceeding, PTB, Quintig, quotation, Realty, recommended, relocate, relocated, relocating, repackaged, repackaging, resigned, Resolution, retention, Royal, Scientelle, Scotland, Silver, SMFM, suppository, TetraLogic, Thailand, tradeable, TransMolecular, Tranzyme, Wharton

Removed: abstract, abuse, achieving, Acusphere, Adair, allocate, allocation, article, ASU, attributed, Bancorp, bar, BS, calling, CD, centrally, challenged, Chicago, civil, CompuServe, computer, consultant, Cornell, corrective, criminal, DeFranco, deliverable, DuPont, EA, Emerging, endometrial, estatio, ew, exclusion, fraud, fraudulent, Georgetown, gynecologic, heading, Helene, herapy, implementation, imprisonment, inadvertent, individually, insufficient, intact, JM, joined, Liposome, McNally, menopausal, modified, Neonatal, obstetrical, OCHIEVE, operation, opportunity, PR, priced, processing, publish, punishable, qui, Rand, recent, Reliant, Robert, Savient, screening, Searle, sponsored, Squibb, statute, stronger, suit, tam, Task, Topic, tradable, unsuccessful, Vical, violated, White, xtending, Zila

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

JNP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Columbia Laboratories, Inc.

Livingston, NJ

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-169599, 333-75275, 333-125671, 333-132803, 333-140107, and 333-155530) and Form S-8 (No. 333-34079, 333-63470, 333-116072, and 333-152008) of Columbia Laboratories, Inc. of our reports dated March 13, 2013, relating to the consolidated financial statements, and the effectiveness of Columbia Laboratories, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K. We also consent to the incorporation by reference of our report dated March 13, 2013 relating to the financial statement schedule, which appears in this Form 10-K.

/s/ BDO USA, LLP

BDO USA, LLP

Woodbridge, NJ

March 13, 2013